Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ADK | P55263 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.32 |
| ▸ | TOP1 | P11387 | 2/20 | 0.32 |
| ▸ | GRM5 | P41594 | 2/20 | 0.31 |
| ▸ | TERT | O14746 | 1/20 | 0.31 |
| ▸ | CYCS | P99999 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14629725 | 0.93 | TDP1 (0.34) | TDP1L3MBTL1ADKMAPK14TOP1 | |
| SCHEMBL14599679 | 0.90 | STAT3 (0.39) | TDP1L3MBTL1TOP1GRM5TERT | |
| SCHEMBL14599698 | 0.81 | FFAR1 (0.39) | TDP1L3MBTL1TOP1CYCS | |
| SCHEMBL14599677 | 0.79 | L3MBTL1 (0.38) | TDP1L3MBTL1 | |
| SCHEMBL14629726 | 0.70 | TERT (0.40) | TOP1TERTCYCS | |
| SCHEMBL9588215 | 0.70 | TOP1 (0.48) | MAPK14TOP1TERTCYCS | |
| SCHEMBL14599687 | 0.69 | TOP1 (0.39) | TOP1TERTCYCS | |
| SCHEMBL14629734 | 0.69 | STAT3 (0.43) | TOP1TERTCYCS | |
| SCHEMBL30092778 | 0.66 | TOP1 (0.60) | TOP1TERTCYCS | |
| SCHEMBL10592809 | 0.66 | TOP1 (0.60) | TOP1TERTCYCS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070015742-A1 | Porphyrin derivatives | YAHIOGLU GOKHAN | 2007-01-18 | — | — | US | disclosed |
| US-20070015742-A1 | Porphyrin derivatives | YAHIOGLU GOKHAN | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015742-A1 | Porphyrin derivatives | SCO2, CBR3, CBR1 | TDP1 4330/4885L3MBTL1 3006/4885ADK 4761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.